Zionexa is pleased to welcome Agnès Guagliardo in Zionexa team as Quality Assurance Manager. Her mission will be to assess Zionexa quality strategy, to handle future audits and regulatory inspections, and to build the future by creating new processes and strengthening current quality systems documentation and processes.
Zionexa is an international company developing and commercializing in-vivo biomarkers for targeted therapies in oncology aimed at improving patients’ pathway and quality of life. Zionexa is actively working on developing its pipeline of molecules, in the US and in Europe, and Agnès will support this by defining and coordinating the quality assurance policy.
Agnès Guagliardo joins Zionexa’s Toulouse office with a strong experience in pharmaceutical industry and quality assurance, especially in sterile and injectable drug products. After her first experiences in cosmetic companies, Agnès worked as Process Engineer consultant in biotechs, pharmaceutical and medical devices industries for 8 years. Most recently, she was Process Validation Engineer Expert at Unither Liquid Manufacturing. She has a Bachelor of Sciences Degree in Life sciences, and also a Science Master’s degree in Project management and Health products industrial engineering.
“Quality must guarantee patient security and safety, but it must also help the company’s improvement and on-going performance. All these criteria must be aligned to ensure evolution and innovation.”, Agnès Guagliardo said.
Commenting on Agnès’s new assignment at Zionexa, Jean-Bernard Deloye, Head of Market Access: “We are pleased to welcome Agnès in order to support the deployment of our production network in collaboration with regulatory affairs. Her experience will allow us to optimize a corporate operational quality system.”
Please join us in welcoming Agnès to the Zionexa team.